Form 4: Surgery Partners CEO Jason Evans Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Surgery Partners CEO Jason Eric Evans sold 9,070 shares of common stock on March 4, 2024, to satisfy tax withholding obligations related to the vesting of restricted stock.
Summary
- On March 4, 2024, Jason Eric Evans, the CEO of Surgery Partners, Inc., sold 9,070 shares of common stock.
- The sale was executed at a weighted average price of $30.61 per share.
- This transaction was to cover tax withholding obligations related to the vesting of restricted stock on March 2, 2024.
- Following the transaction, Evans directly owns 466,494 shares of Surgery Partners, Inc.
Sentiment
Score: 6
Explanation: The document describes a routine transaction (selling shares to cover taxes). It's neutral in itself, but the fact that an executive is selling shares could be perceived slightly negatively by some investors, hence the score.
Industry Context
Sales of shares to cover tax obligations are a routine part of executive compensation, particularly when dealing with restricted stock units. It is a common practice and doesn't necessarily indicate a lack of confidence in the company.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/02/2024 | Restricted stock vested, triggering tax obligations. |
| 03/04/2024 | Jason Eric Evans sold 9,070 shares of Surgery Partners, Inc. common stock. |
| 03/06/2024 | Date of signature for the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.